Skip to main content

Candel Therapeutics, Inc. insider trading

CADLNASDAQ
$10.18+0.02 (+0.20%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+88.2%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • PBPaul B. ManningDirector7.5123%of company
  • CMChristopher MartellDirector0.7147%of company
  • PPPaul Peter TakChief Executive Officer0.1481%of company
  • JCJoseph C. PapaDirector0.1337%of company
  • FBFrancesca BaroneChief Scientific Officer0.1011%of company
  • STSeshu TyagarajanChief Technology Officer0.1005%of company
  • WGWilliam Garrett NicholsChief Medical Officer0.0686%of company
  • CSCharles SchochChief Financial Officer0.0567%of company
  • GJGary J. NabelDirector0.007%of company
  • NLNicoletta LoggiaDirector0.0028%of company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
CADLPaul Peter TakChief Executive OfficerOpen market sell$621K-34.4%$10.46$621KSep 11, 2026Sep 11, 2026
CADLSeshu TyagarajanChief Technology OfficerOpen market sell$84K-8.4%$12.00$84KAug 17, 2026Aug 19, 2026
CADLSeshu TyagarajanChief Technology OfficerOpen market sell$70.2K-7.7%$10.02$70.2KJun 29, 2026Jul 1, 2026
CADLFrancesca BaroneChief Scientific OfficerOpen market sell$236K-23.3%$10.06$236KJun 29, 2026Jul 1, 2026
CADLPaul B. ManningDirectorOpen market purchase$3M+10.6%$5.45$3MFeb 23, 2026Feb 26, 2026
End of history · 5 transactions

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.